Khoso Baluch

2020

In 2020, Khoso Baluch earned a total compensation of $1.2M as Chief Executive Officer at CorMedix, a 31% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$340,000
Option Awards$428,583
Salary$425,000
Other$40,088
Total$1,233,671

Baluch received $428.6K in option awards, accounting for 35% of the total pay in 2020.

Baluch also received $340K in non-equity incentive plan, $425K in salary and $40.1K in other compensation.

Rankings

In 2020, Khoso Baluch's compensation ranked 7,712th out of 13,090 executives tracked by ExecPay. In other words, Baluch earned more than 41.1% of executives.

ClassificationRankingPercentile
All
7,712
out of 13,090
41st
Division
Manufacturing
3,256
out of 5,621
42nd
Major group
Chemicals And Allied Products
1,318
out of 2,254
42nd
Industry group
Drugs
1,142
out of 1,954
42nd
Industry
Pharmaceutical Preparations
851
out of 1,459
42nd
Source: SEC filing on October 29, 2021.

Baluch's colleagues

We found five more compensation records of executives who worked with Khoso Baluch at CorMedix in 2020.

2020

Matthew David

CorMedix

Chief Financial Officer

2020

Phoebe Mounts

CorMedix

General Counsel

2020

Elizabeth Masson-Hurlburt

CorMedix

Executive Vice President and Head of Clinical Operations

2020

John Armstrong

CorMedix

Executive Vice President for Technical Operations

2020

Robert Cook

CorMedix

Chief Financial Officer

News

You may also like